Hu Shuqun, Liu Hua, Ha Yonju, Luo Xuemei, Motamedi Massoud, Gupta Mahesh P, Ma Jian-Xing, Tilton Ronald G, Zhang Wenbo
Institute of Emergency Rescue Medicine, Xuzhou Medical College, Xuzhou, Jiangsu, China; Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, TX 77555-0144, USA.
Center for Biomedical Engineering, The University of Texas Medical Branch, Galveston, TX 77555-0144, USA.
Free Radic Biol Med. 2015 Feb;79:176-85. doi: 10.1016/j.freeradbiomed.2014.11.011. Epub 2014 Dec 2.
The mammalian sirtuin 6 (Sirt6) is a site-specific histone deacetylase that regulates chromatin structure and many fundamental biological processes. It inhibits endothelial cell senescence and inflammation, prevents development of cardiac hypertrophy and heart failure, modulates glucose metabolism, and represses tumor growth. The basic molecular mechanisms underlying regulation of Sirt6 enzymatic function are largely unknown. Here we hypothesized that Sirt6 function can be regulated via posttranslational modification, focusing on the role of peroxynitrite, one of the major reactive nitrogen species formed by excessive nitric oxide and superoxide generated during disease processes. We found that incubation of purified recombinant Sirt6 protein with 3-morpholinosydnonimine (SIN-1; a peroxynitrite donor that generates nitric oxide and superoxide simultaneously) increased Sirt6 tyrosine nitration and decreased its intrinsic catalytic activity. Similar results were observed in SIN-1-treated Sirt6, which was overexpressed in HEK293 cells, and in endogenous Sirt6 when human retinal microvascular endothelial cells were treated with SIN-1. To further investigate whether Sirt6 nitration occurs under pathological conditions, we determined Sirt6 nitration and activity in retina using a model of endotoxin-induced retinal inflammation. Our data showed that Sirt6 nitration was increased, whereas its activity was decreased, in this model. With mass spectrometry, we identified that tyrosine 257 in Sirt6 was nitrated after SIN-1 treatment. Mutation of tyrosine 257 to phenylalanine caused loss of Sirt6 activity and abolished SIN-1-induced nitration and decrease in its activity. Mass spectrometry analysis also revealed oxidation of methionine and tryptophan in Sirt6 after SIN-1 treatment. Our results demonstrate a novel regulatory mechanism controlling Sirt6 activity through reactive nitrogen species-mediated posttranslational modification under oxidative and nitrosative stress.
哺乳动物的沉默信息调节因子6(Sirt6)是一种位点特异性组蛋白脱乙酰酶,可调节染色质结构和许多基本生物学过程。它能抑制内皮细胞衰老和炎症,预防心脏肥大和心力衰竭的发生,调节葡萄糖代谢,并抑制肿瘤生长。Sirt6酶功能调节的基本分子机制在很大程度上尚不清楚。在这里,我们假设Sirt6的功能可以通过翻译后修饰来调节,重点关注过氧亚硝酸盐的作用,过氧亚硝酸盐是疾病过程中由过量一氧化氮和超氧化物产生的主要活性氮物种之一。我们发现,将纯化的重组Sirt6蛋白与3-吗啉代辛二亚胺(SIN-1;一种同时产生一氧化氮和超氧化物的过氧亚硝酸盐供体)孵育,会增加Sirt6酪氨酸硝化并降低其内在催化活性。在用SIN-1处理的HEK293细胞中过表达的Sirt6以及用人视网膜微血管内皮细胞处理SIN-1时的内源性Sirt6中,也观察到了类似的结果。为了进一步研究Sirt6硝化是否在病理条件下发生,我们使用内毒素诱导的视网膜炎症模型测定了视网膜中Sirt6硝化和活性。我们的数据表明,在该模型中,Sirt6硝化增加,而其活性降低。通过质谱分析,我们确定Sirt6中的酪氨酸257在SIN-1处理后被硝化。酪氨酸257突变为苯丙氨酸会导致Sirt6活性丧失,并消除SIN-1诱导的硝化及其活性降低。质谱分析还显示,SIN-1处理后Sirt6中的甲硫氨酸和色氨酸发生了氧化。我们的结果证明了一种新的调节机制,即在氧化和亚硝化应激下,通过活性氮物种介导的翻译后修饰来控制Sirt6活性。